...Exiqon's Oncotech Inc. CLIA-certified lab. Further terms were not disclosed. Exiqon announced plans to liquidate the Oncotech...

...Exiqon plans to cease operations at its Tustin, Calif., CLIA-certified lab Oncotech Inc. and liquidate the assets...
...Oncotech in 2007 to accelerate R&D and establish commercial operations for the company's miRNA-based diagnostics. Oncotech...

...diagnostics R&D in Denmark and divest its Tustin, Calif., CLIA-certified lab Oncotech Inc. The company acquired Oncotech...

...of non-small cell lung cancer (NSCLC) patients to anti-EGFR treatment. The diagnostics unit was formerly Oncotech Inc....

...Exiqon completed the previously announced acquisition of Oncotech for 5.6 million shares valued at DKK208.1 million...
...about DKK225.7 million ($44.9 million) (see BioCentury, Dec. 3, 2007). Exiqon A/S (CSE:EXQ), Copenhagen, Denmark Oncotech Inc....

...A/S (CSE:EXQ), Copenhagen, Denmarks Business: Supply/Service Appointed: Frank Kiesner, formerly CEO of newly acquired subsidiary Oncotech Inc. WIR...

...EXQ will acquire Oncotech for 6.2 million shares valued at DKK225.7 million ($44.9 million) based on...
...on EXQ's close of DKK36.40 on Nov. 26, the day before the deal was announced. Oncotech...
...the company. EXQ said the acquisition will allow it to enter the molecular diagnostics market. Oncotech's...

...cancers. BEC will contribute its automated sample preparation, DNA/RNA hybridization, immunochemistry and flow cytometry, and Oncotech...
...clinical data to develop genetic tests and assay formats. Beckman Coulter Inc. (BEC), Fullerton, Calif. Oncotech Inc....

...cancers. BEC will contribute its automated sample preparation, DNA/RNA hybridization, immunochemistry and flow cytometry and Oncotech...